Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2019-05-14 Major Shareholding Noti…
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Holdings in Company
Major Shareholding Notification Classification · 100% confidence The document is clearly identified by the header 'RNS Number : 8914Y' and contains the standard format for 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is a mandatory regulatory disclosure regarding share ownership thresholds being crossed, making MRQ the most precise classification over the general RNS fallback.
2019-05-14 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory filing about share ownership changes, making MRQ the most precise classification. The date of the event (09/05/2019) and notification (13/05/2019) are present.
2019-05-13 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1504 characters) and contains the header 'RNS Number : 8741Y' and mentions that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, non-standard regulatory event notification. Since it is a direct, brief announcement disseminated via the RNS system and does not fit into the specific categories like ER, 10-K, or DIV, it falls best under the general regulatory announcement category.
2019-05-13 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1487 characters) and contains an 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange'. The content itself is a specific, brief announcement regarding a 'Price Monitoring Extension' for an auction call period, which is a routine market operational update. This type of short, specific regulatory announcement that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified under the general regulatory filing category, RNS, as it is explicitly sourced from the RNS system.
2019-05-13 English
Regulatory and Trading Update
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 0195X' and concludes with information about RNS, the news service of the London Stock Exchange, stating 'This information is provided by RNS...'. The content is a 'Regulatory and Trading Update' detailing clinical trial progress (FDA/PEI meetings, Phase III planning, Phase I/II updates) and commercial trading status. This format—a brief, timely announcement of operational and regulatory news disseminated via the RNS system—is characteristic of a general regulatory filing that doesn't fit the more specific categories like 10-K (Annual Report), ER (Earnings Release), or CT (Call Transcript). Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-04-25 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1506 characters) and contains an 'RNS Number' (2104T) and mentions being provided by 'RNS, the news service of the London Stock Exchange.' The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, short-form operational announcement related to trading mechanisms, not a comprehensive financial report or a standard regulatory filing like 10-K or ER. Since it is a general regulatory announcement that doesn't fit the highly specific categories (like DIV, DIRS, or ER), the most appropriate fallback category is Regulatory Filings (RNS).
2019-03-18 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.